94 related articles for article (PubMed ID: 19281794)
1. PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells.
Zhao M; Duan XF; Wen DH; Chen GQ
Biochem Biophys Res Commun; 2009 May; 382(3):508-13. PubMed ID: 19281794
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ANP32B, a novel substrate of caspase-3, enhances caspase-3 activation and apoptosis induction in myeloid leukemic cells.
Shen SM; Yu Y; Wu YL; Cheng JK; Wang LS; Chen GQ
Carcinogenesis; 2010 Mar; 31(3):419-26. PubMed ID: 20015864
[TBL] [Abstract][Full Text] [Related]
3. Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk.
Navakauskiene R; Treigyte G; Savickiene J; Gineitis A; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():393-402. PubMed ID: 15659822
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 cleavages at two adjacent sites by different caspases promote cisplatin-induced apoptosis.
Zhu J; Yang Y; Wu J
Cell Res; 2007 May; 17(5):441-8. PubMed ID: 17452997
[TBL] [Abstract][Full Text] [Related]
5. BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis.
Liu P; Xu B; Li J; Lu H
FEBS Lett; 2009 Jan; 583(2):401-6. PubMed ID: 19111544
[TBL] [Abstract][Full Text] [Related]
6. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
[TBL] [Abstract][Full Text] [Related]
7. Involvement of both extrinsic and intrinsic apoptotic pathways in apoptosis induced by genistein in human cervical cancer cells.
Kim SH; Kim SH; Lee SC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():196-201. PubMed ID: 19723056
[TBL] [Abstract][Full Text] [Related]
8. NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells.
Chen S; Han YH; Zheng Y; Zhao M; Yan H; Zhao Q; Chen GQ; Li D
Leuk Res; 2009 Aug; 33(8):1108-13. PubMed ID: 19046768
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
Liu H; Wang M; Diao S; Rao Q; Zhang X; Xing H; Wang J
Leuk Res; 2009 Sep; 33(9):1243-8. PubMed ID: 19299014
[TBL] [Abstract][Full Text] [Related]
10. PU.1 silencing leads to terminal differentiation of erythroleukemia cells.
Atar O; Levi BZ
Biochem Biophys Res Commun; 2005 Apr; 329(4):1288-92. PubMed ID: 15766566
[TBL] [Abstract][Full Text] [Related]
11. PU.1 directly regulates retinoic acid-induced expression of RIG-G in leukemia cells.
Gu ZM; Liu CX; Wu SF; Zhao M; Xu HZ; Liu W; Zhou HC; Chen GQ; Wu YL
FEBS Lett; 2011 Jan; 585(2):375-80. PubMed ID: 21176776
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
Blaybel R; Théoleyre O; Douablin A; Baklouti F
Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
[TBL] [Abstract][Full Text] [Related]
13. Identification of annexin 1 as a PU.1 target gene in leukemia cells.
Iseki Y; Imoto A; Okazaki T; Harigae H; Takahashi S
Leuk Res; 2009 Dec; 33(12):1658-63. PubMed ID: 19428102
[TBL] [Abstract][Full Text] [Related]
14. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells.
Kim BM; Choi YJ; Han Y; Yun YS; Hong SH
Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559
[TBL] [Abstract][Full Text] [Related]
15. Nuclear translocation of dihydrofolate reductase is not a pre-requisite for DNA damage induced apoptosis.
Yuan TT; Huang Y; Zhou CX; Yu Y; Wang LS; Zhuang HY; Chen GQ
Apoptosis; 2009 May; 14(5):699-710. PubMed ID: 19360472
[TBL] [Abstract][Full Text] [Related]
16. Purine-rich box-1-mediated reduced expression of CD20 alters rituximab-induced lysis of chronic lymphocytic leukemia B cells.
Mankaï A; Bordron A; Renaudineau Y; Martins-Carvalho C; Takahashi S; Ghedira I; Berthou C; Youinou P
Cancer Res; 2008 Sep; 68(18):7512-9. PubMed ID: 18794139
[TBL] [Abstract][Full Text] [Related]
17. Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms.
Song MG; Gao SM; Du KM; Xu M; Yu Y; Zhou YH; Wang Q; Chen Z; Zhu YS; Chen GQ
Blood; 2005 May; 105(9):3714-21. PubMed ID: 15671440
[TBL] [Abstract][Full Text] [Related]
18. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
19. SAHA treatment overcomes the anti-apoptotic effects of Bcl-2 and is associated with the formation of mature PML nuclear bodies in human leukemic U937 cells.
Lee JS; Jeong SH; Soung YH; Kim TH; Choi HJ; Park BS; Kwon TK; Yoo YH
Chem Biol Interact; 2009 Sep; 181(1):61-70. PubMed ID: 19631782
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
